Scientists probe Japan's remarkable COVID success in hunt for new vaccine
While many factors likely boosted Japan's COVID resilience, researchers say a possible cellular-level advantage could help them create a new weapon against the virus.
Watch CBS News
While many factors likely boosted Japan's COVID resilience, researchers say a possible cellular-level advantage could help them create a new weapon against the virus.
Who should get the vaccine? Are there side effects? What about boosters? Here's everything you need to know.
The FDA and CDC have authorized COVID-19 vaccines for kids as young as 6 months old. President Biden and first lady Jill Biden are expected to tour a D.C. vaccine clinic to highlight the safety and effectiveness of the vaccines. Dr. Susannah Hills, a pediatric airway surgeon and assistant professor of ENT at Columbia University, joined CBS News' John Dickerson to discuss.
The CDC is recommending Pfizer and Moderna's COVID-19 vaccines for kids as young as 6 months old. Dr. Jerry Abraham joins CBS News' Tanya Rivero and Tony Dokoupil to discuss why it's important for children to get the shot.
White House Director of the National Economic Council Brian Deese, Dr. Scott Gottlieb, Rep. Zoe Lofgren and more appear on "Face the Nation with Margaret Brennan" this Sunday.
CBS News medical contributor Dr. David Agus joined Anne-Marie Green and Vladimir Duthiers to answer all your questions about COVID-19.
In a major step, a Food and Drug Administration panel has recommended authorizing Moderna's two-dose COVID-19 vaccine for children under the age of 6, and Pfizer's three-dose vaccine for children under the age of 5. CBS News correspondent Meg Oliver reports, and then Denis Nash, professor of epidemiology from the CUNY Graduate School of Public Health, discusses the latest developments.
The FDA's panel of vaccine advisers voted unanimously that the benefits of Pfizer's and Moderna's shots outweigh the risks in young children.
The FDA's vaccine advisory panel is meeting today to vote on Pfizer and Moderna's COVID-19 shots for children 5 and under. That same committee voted Tuesday to endorse Moderna's shot for kids ages 6 to 17. CBS News medical contributor Dr. David Agus explains what parents need to know before the FDA and CDC give their final approval.
A panel of advisers to the U.S. Food and Drug Administration is meeting Wednesday to consider approving Pfizer and Moderna's COVID-19 vaccines for young children. Dr. Dyan Hes, founder and medical director of Gramercy Pediatrics in New York City, speaks to "CBS News Mornings" about what parents should know before scheduling vaccination appointments for their kids.
The White House says doses will be available everywhere from pediatricians' offices to children's museums, if health authorities sign off on the shots later this month.
The FDA's vaccine advisers meet later this month to weigh updating booster shots.
The rate of COVID-19 infections is still highest among the unvaccinated, according to figures through April.
Recent data from the CDC shows boosted Americans are catching COVID-19 higher rates than those who have not been boosted - although the boosters help protect against hospitalizations and deaths. Professor John Moore from Weill Cornell Medical College joined CBS News' Anne-Marie Green and Errol Barnett to explain what's behind these numbers.
The company says it'll give U.S. regulators the data soon. Moderna is already seeking U.S. clearance to vaccinate kids 5 and under.
The three cadets will get degrees but "will not be commissioned into the United States Air Force as long as they remain unvaccinated," an Academy spokesperson said.
The CDC published updated data Thursday on counties at "medium" and "high" levels of COVID-19.
The growing coronavirus outbreak in North Korea has global health experts concerned about how the nation is handling the pandemic. CBS News' Tanya Rivero and Nancy Chen spoke with Sue Mi Terry, director of the Wilson Center's Asia Program, about the problems in North Korea.
A federal judge could decide this week whether to lift the Title 42 immigration policy. The CDC announced in April it was ending the public health policy, saying it's no longer necessary given the current state of the coronavirus pandemic and resources available to fight COVID-19. But proponents of the policy say health care and law enforcement systems would be overwhelmed by an influx of migrants if Title 42 ends. CBS News immigration reporter Camilo Montoya-Galvez spoke with the Department of Homeland Security's chief medical officer about what officials are doing to ensure migrants are protected from COVID-19.
White House officials warn that the U.S. could see 100 million new COVID-19 cases in the fall and winter months if Congress fails to increase federal funding to fight the pandemic. Dr. Celine Gounder, senior fellow and editor-at-large for public health at Kaiser Health News, joins "CBS News Mornings" with the latest.
President Joe Biden is ordering flags to fly at half-staff as the White House marks 1 million COVID-related deaths in the U.S. He's also calling on Congress to pass the stalled $10 billion COVID package. CBS News senior White House and political correspondent Ed O'Keefe has more from Washington.
The U.S. is close to seeing 1 million COVID-related deaths as the pandemic enters yet another phase. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and chief medical adviser to the president, joined CBS News to discuss this grim milestone and the possibility of the country entering an endemic phase with the virus.
The FDA says the Johnson and Johnson COVID-19 vaccine should be used as a last resort due to rare but potentially severe blood clots. CBS News medical contributor Dr. David Agus joins Vladimir Duthiers and Anne-Marie Green to discuss on the latest developments.
The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine.
COVID-19 cases are rising again and the U.S. death toll is nearing one million. Dr. Celine Gounder, an infectious disease specialist and editor-at-large for public health at Kaiser Health News, joins CBS News' Tanya Rivero and Mola Lenghi to discuss the spread of a new Omicron subvariant and guidelines for travelers.